Naonobu Sugiyama
4PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 21, 2026
Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis.Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka
|Jul 27, 2024
Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study.Yoshiya Tanaka, Mitsumasa Kishimoto, Koshiro Sonomoto
|Jul 17, 2024
Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry.Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue
|Dec 31, 2023
Validation of claims-based algorithms for rheumatoid arthritis in Japan: Results from the VALIDATE-J study.Naonobu Sugiyama, Mitsuyo Kinjo, Sadao Jinno
Pageof 1
Frequent Collaborators
3 joint publications
Yoshiya Tanaka
3 joint publications
Hisashi Yamanaka
2 joint publications
Masayoshi Harigai
2 joint publications
Shigeyuki Toyoizumi
1 joint publications
Eiichi Tanaka
1 joint publications
Eisuke Inoue
1 joint publications
Ryoko Sakai
1 joint publications
Naohiro Sugitani
1 joint publications
Mitsumasa Kishimoto
1 joint publications
Koshiro Sonomoto
